In particular, local in vivo microinjection of clodronate liposomes into SGs simultaneously inhibits CHF-induced elevation of TNFα and IL-1β, increases in N-type Ca2+ currents, and cardiac sympathetic overactivation. This evidence concerns the gene IL1B and congestive heart failure.